Yifan Pharmaceutical Co., Ltd.
Símbolo: 002019.SZ
SHZ
11.4
CNYPrecio de mercado actual
-33.8207
Ratio PER
0.4747
Ratio PEG
13.89B
Capitalización MRK
- 0.00%
Rendimiento DIV
Yifan Pharmaceutical Co., Ltd. (002019-SZ) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3477.57 | 773.4 | 1239.3 | 1336.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 345.01 | 75 | 95.5 | -62.1 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 5608.97 | 1390.5 | 1527.3 | 1391 | |||||||||||||||||||||||
balance-sheet.row.inventory | 3879.32 | 928.6 | 831 | 663.9 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 637.11 | 158.6 | 92.4 | 194.5 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 13602.98 | 3251.1 | 3689.9 | 3585.5 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 6805.25 | 1811.8 | 1601.4 | 1642.8 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 10950.38 | 2737.4 | 2737.8 | 2737.8 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 12107.43 | 2605.6 | 3298.7 | 3091.4 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 23057.8 | 5343 | 6036.5 | 5829.2 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2619.46 | 718.5 | 601.2 | 702.2 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 1129.77 | 257.8 | 290.8 | 244.4 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 992.6 | 117.4 | 323.7 | 161 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 34604.87 | 8248.4 | 8853.6 | 8579.6 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 48207.85 | 11499.6 | 12543.5 | 12165.1 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 1628.12 | 431.4 | 288.4 | 350.9 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 4633.39 | 1116.4 | 1231.2 | 1438.9 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 219.64 | 19.1 | 107.5 | 82.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 3295.67 | 812 | 930.9 | 820.3 | |||||||||||||||||||||||
Deferred Revenue Non Current | 397.93 | 99.7 | 104.8 | 85.7 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 383.83 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 1089.05 | 506.4 | 476.5 | 7.5 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 4200.61 | 957.6 | 1197.9 | 1088.7 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 269.78 | 66.7 | 80.7 | 89.8 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 12952.29 | 3144.9 | 3397.3 | 3390.6 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 4185.27 | 1046.3 | 1046.3 | 1054.4 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 18318.97 | 4204.1 | 4754.6 | 4562.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 6739.51 | 200.9 | 27.2 | 76.4 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 5406.71 | 2824.4 | 2983.4 | 2842.3 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 34650.46 | 8275.6 | 8811.5 | 8535.2 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 48207.85 | 11499.6 | 12543.5 | 12165.1 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 505.36 | -20.7 | 334.8 | 239.4 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 35155.81 | 8254.9 | 9146.2 | 8774.6 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 48207.85 | - | - | - | |||||||||||||||||||||||
Total Investments | 2964.47 | 793.5 | 696.7 | 640.1 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 8055.08 | 1995.2 | 2162.1 | 2259.2 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 4922.52 | 1296.8 | 1018.3 | 923.1 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -469.75 | 127.2 | 242.2 | 931.4 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 18.71 | 228.4 | 207.2 | 177 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -53.9 | -87 | -33.4 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 53.9 | -7 | 82.8 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -97.84 | -168.2 | -285.4 | -178.5 | ||||||||||||||||||||
cash-flows.row.account-receivables | -10.25 | -103.8 | -18.6 | -117.7 | ||||||||||||||||||||
cash-flows.row.inventory | -109.39 | -167.1 | -80.5 | 21.9 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | 156.6 | -99.3 | -49.2 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 21.79 | -53.9 | -87 | -33.4 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 1043.98 | 284.7 | 231.3 | 129.2 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 495.1 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -516.29 | -542.3 | -571.7 | -715.7 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 11.1 | 1.2 | -26.1 | -36.8 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | -1437.41 | -1253.6 | -1265 | -1141 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1404.08 | 1118 | 1337.2 | 1122 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -349.06 | 6.5 | 17.7 | 1 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -538.51 | -670.2 | -507.9 | -770.6 | ||||||||||||||||||||
cash-flows.row.debt-repayment | -754.5 | -1880.3 | -2432.7 | -2210 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.8 | 1 | 1.6 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -38 | -53.6 | -121.5 | -1.6 | ||||||||||||||||||||
cash-flows.row.dividends-paid | -68.79 | -86.4 | -138.4 | -202 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 569.44 | 2006.7 | 2913.7 | 1844 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -78.12 | -12.7 | 222.2 | -567.9 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 16.15 | 59.6 | -20.9 | 1.3 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -45.08 | -151.2 | -5.4 | -228.7 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 3004.74 | 711.6 | 862.8 | 868.2 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 3049.83 | 862.8 | 868.2 | 1096.8 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 495.1 | 472.1 | 301.2 | 1108.5 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -516.29 | -542.3 | -571.7 | -715.7 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -21.2 | -70.2 | -270.5 | 392.8 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 4433.29 | 4022.2 | 3836.6 | 4409 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 2354.45 | 2191.3 | 1970.7 | 2580.7 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 2078.84 | 1830.9 | 1865.9 | 1828.4 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 320.03 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 115.55 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1184.2 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -859.52 | -26.3 | 161.9 | 248.2 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 2783.92 | 1821.4 | 1525 | 1476.3 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 5138.37 | 4012.7 | 3495.7 | 4057 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 16.25 | 13.1 | 21.4 | 25.3 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 71.66 | 75.6 | 85.8 | 74.6 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1184.2 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 55.19 | -859.2 | -242.6 | -137.8 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -859.52 | -26.3 | 161.9 | 248.2 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 55.19 | -859.2 | -242.6 | -137.8 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 71.66 | 75.6 | 85.8 | 74.6 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 248.89 | 279.8 | 228.4 | 207.2 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -554.16 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | -800.46 | 9.5 | 399.4 | 348.6 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | -745.27 | -849.8 | 156.7 | 210.8 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 56.73 | 16.6 | 29.6 | -31.4 | |||||||||||||||||||||||
income-statement-row.row.net-income | -469.75 | -551.1 | 127.2 | 278.4 |
Preguntas frecuentes
Cuánto es Yifan Pharmaceutical Co., Ltd. (002019.SZ) activos totales?
Yifan Pharmaceutical Co., Ltd. (002019.SZ) los activos totales son 11499585782.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 2441543691.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.469.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es -0.017.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es -0.106.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son -0.181.
¿Qué es Yifan Pharmaceutical Co., Ltd. (002019.SZ) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es -551073063.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 1995190642.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 1821437913.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 810555981.000.